Aflac Incorporated (NYSE:AFL) Shares Sold by OLD National Bancorp IN

OLD National Bancorp IN reduced its holdings in Aflac Incorporated (NYSE:AFL) by 2.2% during the 3rd quarter, Holdings Channel reports. The firm owned 18,744 shares of the financial services provider’s stock after selling 417 shares during the quarter. OLD National Bancorp IN’s holdings in Aflac were worth $2,096,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Strategic Financial Concepts LLC grew its stake in Aflac by 7,001.0% in the 2nd quarter. Strategic Financial Concepts LLC now owns 667,706 shares of the financial services provider’s stock valued at $596,000 after acquiring an additional 658,303 shares during the period. Truist Financial Corp grew its position in shares of Aflac by 26.6% in the second quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider’s stock valued at $172,338,000 after purchasing an additional 405,847 shares during the period. Swedbank AB purchased a new stake in shares of Aflac during the first quarter worth about $27,588,000. Dimensional Fund Advisors LP raised its position in shares of Aflac by 6.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider’s stock worth $429,319,000 after purchasing an additional 285,576 shares during the last quarter. Finally, Envestnet Asset Management Inc. raised its position in shares of Aflac by 27.6% during the 2nd quarter. Envestnet Asset Management Inc. now owns 1,243,189 shares of the financial services provider’s stock worth $111,029,000 after purchasing an additional 268,694 shares during the last quarter. 67.44% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Aflac

In related news, Director Thomas J. Kenny sold 2,000 shares of Aflac stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total value of $197,880.00. Following the completion of the sale, the director now owns 18,158 shares in the company, valued at approximately $1,796,552.52. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.90% of the company’s stock.

Aflac Trading Down 0.4 %

AFL opened at $114.50 on Monday. The stock has a market capitalization of $65.06 billion, a PE ratio of 12.64, a P/E/G ratio of 2.62 and a beta of 0.95. Aflac Incorporated has a one year low of $75.07 and a one year high of $115.50. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.10 and a current ratio of 0.10. The business’s 50 day moving average price is $109.40 and its 200 day moving average price is $95.98.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.83 EPS for the quarter, beating the consensus estimate of $1.60 by $0.23. The business had revenue of $5.14 billion for the quarter, compared to analyst estimates of $4.10 billion. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The company’s quarterly revenue was down .7% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.58 EPS. As a group, equities research analysts expect that Aflac Incorporated will post 6.76 EPS for the current year.

Aflac Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.75%. The ex-dividend date was Wednesday, August 21st. Aflac’s dividend payout ratio (DPR) is 22.08%.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Morgan Stanley boosted their price objective on Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a research note on Monday, August 19th. Truist Financial raised their price objective on Aflac from $82.00 to $100.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Citigroup upped their target price on shares of Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a report on Tuesday, July 23rd. Barclays began coverage on shares of Aflac in a research note on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 price target on the stock. Finally, Wells Fargo & Company upped their price objective on shares of Aflac from $90.00 to $106.00 and gave the company an “equal weight” rating in a research note on Thursday, October 10th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $97.53.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.